Neutrophil-related molecular targets

Neutrophil-related molecular targets is a collective term for a diverse array of proteins that mediate the biological activities of neutrophils, the most abundant white blood cells in human circulation. These targets include G protein-coupled receptors like CXCR1 and CXCR2, which are essential for chemotaxis, and enzymes such as neutrophil elastase and myeloperoxidase, which facilitate pathogen destruction and tissue degradation (Source: PubMed, PMID: 29030466). While neutrophils are vital for host defense, their excessive activation is a hallmark of inflammatory diseases, including chronic obstructive pulmonary disease (COPD), cystic fibrosis, and rheumatoid arthritis (Source: Nature Reviews Immunology, doi:10.1038/nri.2017.123). Furthermore, neutrophils in the tumor microenvironment can promote cancer progression and metastasis, making them attractive targets for oncology (Source: Cancer Cell, doi:10.1016/j.ccell.2019.02.003). Pharmacological interventions targeting these molecules include elastase inhibitors like alvelestat and CXCR1/2 antagonists like reparixin, which aim to dampen the inflammatory response. Because this entry represents a broad functional category rather than a single specific molecule, it is considered an incorrect or overly broad designation for a therapeutic target.

Other names

Neutrophil targetsNeutrophil-associated targetsNeutrophil-derived proteins

Inhibition of neutrophil-specific enzymes such as neutrophil elastase and myeloperoxidase, or antagonism of receptors involved in neutrophil recruitment and activation like CXCR1 and CXCR2.